Evidence map›Paper›PMID 41603331›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition.

Phoebe Scollard, Shubhabrata Mukherjee, Seo-Eun Choi, Michael L Lee, Brandon Klinedinst, Laura E Gibbons, Emily H Trittschuh, Jesse Mez, Andrew J Saykin, Bryan D James and 2 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Phoebe ScollardDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-4094-938X
Shubhabrata MukherjeeDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-2522-2884
Seo-Eun ChoiDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-2163-688X
Michael L LeeDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-3112-1214
Brandon KlinedinstDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-2697-1852
Laura E GibbonsDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0001-5054-2543
Emily H TrittschuhDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.ORCID 0000-0003-0557-1542
Jesse MezDepartment of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0003-1438-5442
Andrew J SaykinDepartment of Radiology and Imaging Services, Indiana University, Indianapolis, IN, USA.ORCID 0000-0002-1376-8532
Bryan D JamesRush Alzheimer's Disease Center, Chicago, IL, USA.ORCID 0000-0003-1932-151X
Cécile Proust-LimaUniv. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, France.ORCID 0000-0002-9884-955X
Paul K CraneDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-4278-7465

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
Peripheral and Central Biomarkers of Alzheimer's Disease in Diverse CohortsU19AG074879 · NIA · MAYO CLINIC JACKSONVILLE · PI Mariet Allen · 2023 to 2026
$42.0M
MVP Data Integration into the ADSP Phenotype Harmonization ConsortiumU24AG074855 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CUCCARO, MICHAEL L, HOHMAN, TIMOTHY J · 2021 to 2025
$37.5M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDREW J SAYKIN · 2021 to 2026
$24.1M
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease BiobanksU01AG068057 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christos Davatzikos, Heng Huang · 2020 to 2026
$20.7M
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems BiologyU01AG072177 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LEE, DONG YOUNG, NHO, KWANGSIK TIMOTHY · 2021 to 2025
$11.2M
Memory Circuitry in MCI and Early Alzheimer’s Disease Prodrome: Molecular DriversR01AG019771 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 2001 to 2021
$6.9M
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's DiseaseR01AG057739 · NIA · TRUSTEES OF INDIANA UNIVERSITY · PI APOSTOLOVA, LIANA G, PERRY, BREA LOUISE · 2018 to 2022
$3.5M
Predictors and consequences of the timing and accuracy of clinical dementia diagnosisR01AG072559 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Bryan David James · 2022 to 2026
$2.9M
NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG066509NIA NIH HHS P30 AG072976NIA NIH HHS P30 AG072978NIA NIH HHS R01 AG019771NIA NIH HHS R01 AG057739NIA NIH HHS R01 AG068193NIA NIH HHS R01 AG072559NIA NIH HHS T32 AG071444NIA NIH HHS U01 AG068057NIA NIH HHS U01 AG072177NIA NIH HHS U19 AG024904NIA NIH HHS U19 AG074879NIA NIH HHS U24 AG074855NLM NIH HHS R01 LM013463
6 · The paper itself

Abstract

BackgroundOthers have examined heterogeneity in Alzheimer's disease (AD); however, few have used longitudinal data while accounting for variation in disease stage. We used latent classes to model heterogeneity in the trajectories of three cognitive domains (memory, language, and executive functioning) starting at AD dementia diagnosis.ObjectiveOur aim was to describe the patterns of heterogeneity in cognitive decline across cognitive domains during the course of AD and to contextualize our findings by assessing associations with demographic factors and neuropathological measures.MethodsWe used cognitive data from the Religious Orders Study, the Rush Memory and Aging Project, and the Minority Aging Research Study in a multi-dimensional joint latent class mixed model, which allowed us to estimate cognitive trajectories that varied across cognitive domains and latent classes. We accounted for the uncertainty in latent class assignment and corrected for multiple hypotheses when assessing the association of the latent classes with demographic and neuropathological variables.ResultsWe identified five latent classes differentiated by level of impairment (high to low) and rate of decline (slow to fast). Within each latent class, the pattern of decline did not differ substantially across cognitive domains. Classes were associated with

Indexed as

Alzheimer DiseaseCognitionCognitive DysfunctionAgedAged, 80 and overDisease ProgressionExecutive FunctionFemaleHumansLongitudinal StudiesMaleMemoryNeuropsychological TestsAlzheimer's diseasecognitive declinelatent class analysislongitudinal studiesneuropathology

Identifiers

PMID41603331
PMCPMC12934236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.